Skip to search formSkip to main contentSkip to account menu

beta-lactamase OXA-14

Known as: beta-lactamase OXA-10, aspartyl(157)-, OXA-14, 157-Asp-beta-lactamase OXA-10 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Objectives Characterization of the mechanisms driving ceftolozane/tazobactam resistance development in 5 of 47 (10.6%) patients… 
2018
2018
A prospective, descriptive observational study of consecutive patients treated with ceftolozane/tazobactam in the reference… 
2016
2016
Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic bacterium that frequently causes nosocomial infections. New generation… 
2011
2011
Sir, Resistance to cephalosporins of the third and fourth generations in Enterobacteriaceae is an increasing problem worldwide… 
2006
2006
BACKGROUND AND PURPOSE Data on the epidemiology of OXA-type extended-spectrum beta (beta)-lactamases (ESBLs) are limited due to… 
Highly Cited
2005
Highly Cited
2005
Sir, In2002,wesawtheemergenceofcarbapenemresistanceinclinical isolates of Acinetobacter baumannii isolated from patients at two… 
1999
1999
Several extended-spectrum beta-lactamases (ESBLs) belonging to molecular Class D have been described from Pseudomonas aeruginosa… 
Highly Cited
1995
Highly Cited
1995
Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI 6.2 beta-lactamase determined by plasmid pMLH53 and… 
1995
1995
Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI 6.2 beta-lactamase determined by plasmid pMLH53 and…